CD8+ T cells also attack cancer cells and play a primary role in mediating anticancer immunity, although CD4+ T cells facilitate the generation and maintenance of CD8+ effector T cells through cytokine production and activation of APCs [10,11]. Here, CD8A is linked to cancer.